Anthony C Keech

Cost-effectiveness of Evolocumab Therapy for Reducing Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease

Peter Lindgren, Yi Qian, Ben van Hout, 2017, JAMA cardiology.

Statistical methods in clinical trials

Val J Gebski, V. Gebski, A. Keech, 2003, The Medical journal of Australia.

The need for a large-scale trial of fibrate therapy in diabetes: the rationale and design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. [ISRCTN64783481]

James D. Best, Marja-Riitta Taskinen, Philip J. Barter, 2004, Cardiovascular diabetology.

Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up

David Colquhoun, Stephen MacMahon, Andrew Tonkin, 2002, The Lancet.

HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials

Hynek Pikhart, Bengt Sennblad, Tom R. Gaunt, 2015, The Lancet.